Poster Oral Presentation 2

[PO-014] Pregnancy outcomes in the etrasimod clinical program

Dana Verbovsky, Krisztina B Gecse¹, María Chaparro², Maria T Abreu³, Yvette Leung⁴, Elena Sonnenberg⁵, Aoibhinn McDonnell⁶, Krisztina Lazin⁷, Joseph Wu⁸, Christina C Smith⁹, Márjori Dulcine¹⁰, *Karolina Wosik¹¹ (1. Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands, 2. Department of Gastroenterology, Hospital Universitario de La Princesa, IIS Princesa, UAM, CIBERehd, Madrid, Spain, 3. F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai, Los Angeles, CA, USA, 4. Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 5. Medizinische Klinik m. S. Gastroenterologie, Infektiologie und Rheumatologie, Charité-Universitätsmedizin Berlin, Berlin, Germany, 6. Pfizer Ltd, Sandwich, UK, 7. Pfizer AG, Zürich, Switzerland, 8. Pfizer Inc, Cambridge, MA, USA, 9. Pfizer Inc, Collegeville, PA, USA, 10. Pfizer Brazil, São Paulo, Brazil, 11. Pfizer Canada, Kirkland, QC, Canada)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.